{"id":193275,"date":"2022-11-15T08:31:49","date_gmt":"2022-11-15T08:31:49","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=193275"},"modified":"2022-11-15T08:31:49","modified_gmt":"2022-11-15T08:31:49","slug":"acute-intermittent-porphyria","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/acute-intermittent-porphyria\/","title":{"rendered":"Acute intermittent porphyria"},"content":{"rendered":"<p>A rare metabolic disorder inherited as an autosomal dominant trait. It is characterized by excessive excretion of porphyrins, episodes of acute abdominal pain, sensitivity to light, and neurological disturbances. The disorder is sometimes precipitated by the excessive use of sulfonamides, barbiturates, or other drugs.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A rare metabolic disorder inherited as an autosomal dominant trait. It is characterized by excessive excretion of porphyrins, episodes of acute abdominal pain, sensitivity to light, and neurological disturbances. The disorder is sometimes precipitated by the excessive use of sulfonamides, barbiturates, or other drugs. &nbsp;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-193275","post","type-post","status-publish","format-standard","hentry","category-a"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Acute intermittent porphyria - Definition of Acute intermittent porphyria<\/title>\n<meta name=\"description\" content=\"A rare metabolic disorder inherited as an autosomal dominant trait. It is characterized by excessive excretion of porphyrins, episodes of acute abdominal pain, sensitivity to light, and neurological disturbances. The disorder is sometimes precipitated by the excessive use of sulfonamides, barbiturates, or other drugs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/acute-intermittent-porphyria\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acute intermittent porphyria - Definition of Acute intermittent porphyria\" \/>\n<meta property=\"og:description\" content=\"A rare metabolic disorder inherited as an autosomal dominant trait. It is characterized by excessive excretion of porphyrins, episodes of acute abdominal pain, sensitivity to light, and neurological disturbances. The disorder is sometimes precipitated by the excessive use of sulfonamides, barbiturates, or other drugs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/acute-intermittent-porphyria\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-15T08:31:49+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/acute-intermittent-porphyria\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/acute-intermittent-porphyria\/\",\"name\":\"Acute intermittent porphyria - Definition of Acute intermittent porphyria\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2022-11-15T08:31:49+00:00\",\"dateModified\":\"2022-11-15T08:31:49+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A rare metabolic disorder inherited as an autosomal dominant trait. It is characterized by excessive excretion of porphyrins, episodes of acute abdominal pain, sensitivity to light, and neurological disturbances. The disorder is sometimes precipitated by the excessive use of sulfonamides, barbiturates, or other drugs.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/acute-intermittent-porphyria\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/acute-intermittent-porphyria\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/acute-intermittent-porphyria\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acute intermittent porphyria\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acute intermittent porphyria - Definition of Acute intermittent porphyria","description":"A rare metabolic disorder inherited as an autosomal dominant trait. It is characterized by excessive excretion of porphyrins, episodes of acute abdominal pain, sensitivity to light, and neurological disturbances. The disorder is sometimes precipitated by the excessive use of sulfonamides, barbiturates, or other drugs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/acute-intermittent-porphyria\/","og_locale":"en_US","og_type":"article","og_title":"Acute intermittent porphyria - Definition of Acute intermittent porphyria","og_description":"A rare metabolic disorder inherited as an autosomal dominant trait. It is characterized by excessive excretion of porphyrins, episodes of acute abdominal pain, sensitivity to light, and neurological disturbances. The disorder is sometimes precipitated by the excessive use of sulfonamides, barbiturates, or other drugs.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/acute-intermittent-porphyria\/","og_site_name":"Glossary","article_published_time":"2022-11-15T08:31:49+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/acute-intermittent-porphyria\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/acute-intermittent-porphyria\/","name":"Acute intermittent porphyria - Definition of Acute intermittent porphyria","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2022-11-15T08:31:49+00:00","dateModified":"2022-11-15T08:31:49+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A rare metabolic disorder inherited as an autosomal dominant trait. It is characterized by excessive excretion of porphyrins, episodes of acute abdominal pain, sensitivity to light, and neurological disturbances. The disorder is sometimes precipitated by the excessive use of sulfonamides, barbiturates, or other drugs.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/acute-intermittent-porphyria\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/acute-intermittent-porphyria\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/acute-intermittent-porphyria\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Acute intermittent porphyria"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/193275","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=193275"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/193275\/revisions"}],"predecessor-version":[{"id":193276,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/193275\/revisions\/193276"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=193275"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=193275"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=193275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}